FDA warns of serious genital infection linked to SGLT2 inhibitors - Hallo friendsAVOID CANCER AND OTHER DISEASES, In the article you read this time with the title FDA warns of serious genital infection linked to SGLT2 inhibitors, We have prepared this article for you to read and retrieve information therein. Hopefully the contents of postings Article CANCER, Article OTHER DISEASES, Article TREATMENT, We write this you can understand. Alright, good read.

Title : FDA warns of serious genital infection linked to SGLT2 inhibitors
link : FDA warns of serious genital infection linked to SGLT2 inhibitors

FDA warns of serious genital infection linked to SGLT2 inhibitors

It was Graham that first spotted this article … 

(Reuters) - The U.S. Food and Drug Administration (FDA) said on Wednesday a serious genital infection has been reported in patients taking a certain class of diabetes drugs, with one death and 11 others hospitalized.

The warning pertains to a class of medicines called SGLT2 inhibitors, first approved in 2013 to lower blood sugar in adults with type 2 diabetes.

The U.S. health regulator has also called for including this risk in the drugs’ labeling.
The SGLT2 inhibitors approved by the FDA include Johnson & Johnson’s Invokana, Eli Lilly & Co’s Jardiance, as well those from Bristol-Myers Squibb, Astra Zeneca Plc, Merck & Co and Pfizer Inc.

The companies did not immediately respond to Reuters request for comment.

Patients are at risk of the infection known as Fournier’s gangrene, an extremely rare but life-threatening bacterial infection of the tissue under the skin that surrounds the genital area, the FDA said in a statement.

The bacteria usually enter the body through a cut and quickly spread. Having diabetes is a risk factor for developing Fournier’s gangrene.

The FDA said it identified 12 cases of Fournier’s gangrene - 7 in men and 5 in women - between March 2013 and May 2018.

One patient died, while some required multiple disfiguring surgeries and developed complications, the agency said.

The infection developed within several months of the patients starting an SGLT2 inhibitor and the drug was stopped in most cases, the FDA said.

https://uk.reuters.com/article/us-diabetesdrugs-fda/fda-warns-of-serious-genital-infection-linked-to-certain-diabetes-drugs-idUKKCN1LE2PQ

Other serious side effects include:

Graham says, "I think I'll stick with low carb where in most T2 diabetics the need for these drugs is eliminated"

Eddie says, "Readers may like to read this blogs 'Introduction to low-carb for beginners' post" - find it here

All the best Jan, Eddie and Graham

         (The Low Carb Team)

Thus Article FDA warns of serious genital infection linked to SGLT2 inhibitors

That's an article FDA warns of serious genital infection linked to SGLT2 inhibitors This time, hopefully can give benefits to all of you. well, see you in posting other articles.

You are now reading the article FDA warns of serious genital infection linked to SGLT2 inhibitors with the link address https://avoidcancerz.blogspot.com/2018/08/fda-warns-of-serious-genital-infection.html

Tweet

Subscribe to receive free email updates: